These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16756632)

  • 41. [Study of a biochemical concept of experimental psychoses. IX. Effect of prolonged administration of desoxyephedrine (pervitine) and iproniazid (marsilid) on body fluid balance and cerebral metabolism of the waking rabbit].
    CAHN J; HEROLD M; DUBRASQUET M; BARRE N; ALANO J; BRETON Y
    C R Seances Soc Biol Fil; 1958; 152(12):1671-3. PubMed ID: 13639465
    [No Abstract]   [Full Text] [Related]  

  • 42. [Relations between kidney function and body fluids in children].
    ROHWEDDER HJ
    Medizinische; 1959 Jun; 4(26):1268-70. PubMed ID: 13673906
    [No Abstract]   [Full Text] [Related]  

  • 43. Kidney control of fluid balance.
    ANSLOW WP
    Brookhaven Symp Biol; 1957 Jun 12-14; (10):177-96. PubMed ID: 13546678
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of magnesium reload on the ionic equilibrium, the electrocardiogram and the intensity-duration curves].
    MICHON P; LARCAN A; GUERCY O; KLING C
    Ann Biol Clin (Paris); 1958; 16(10-12):604-35. PubMed ID: 13617671
    [No Abstract]   [Full Text] [Related]  

  • 45. [Electrolyte changes in kidney diseases].
    ORTIZ DE LANDAZURI E; ESPINAR LAFUENTE M; SANCHEZ AGESTA A; NUNEZ CARRIL J; DIAZ NOGALES J
    Rev Clin Esp; 1958 Sep; 70(5):280-91. PubMed ID: 13624208
    [No Abstract]   [Full Text] [Related]  

  • 46. [The kidney as the organ regulating the osmolarity of extracellular fluids].
    CORONIL C
    Rev Venez Urol; 1962; 14():189-203. PubMed ID: 14023123
    [No Abstract]   [Full Text] [Related]  

  • 47. [Behavior of extracellular fluid during prednisone therapy].
    DAINOTTO F; FRANCO PL
    Arch Sci Med (Torino); 1958 Jun; 105(6):652-68. PubMed ID: 13560214
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diamox, electrolytic & renal changes].
    REAL AP
    Dia Med; 1957 Jun; 29(35):1100; passim. PubMed ID: 13447714
    [No Abstract]   [Full Text] [Related]  

  • 49. [Organic purification functions].
    SARGO LF
    Sem Med; 1962 Oct; 121():1585. PubMed ID: 13991484
    [No Abstract]   [Full Text] [Related]  

  • 50. [The pineal body & kidney function].
    GIORODANO G; ALCOZER G; ABBONA C
    Arch Maragliano Patol Clin; 1957 Jun; 13(3):465-71. PubMed ID: 13459584
    [No Abstract]   [Full Text] [Related]  

  • 51. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.
    Nesti L; Tricò D; Mengozzi A; Natali A
    Cardiovasc Diabetol; 2021 May; 20(1):109. PubMed ID: 34006325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear receptors in the kidney during health and disease.
    Libby AE; Jones B; Lopez-Santiago I; Rowland E; Levi M
    Mol Aspects Med; 2021 Apr; 78():100935. PubMed ID: 33272705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome proliferator activating receptor-γ and the podocyte.
    Platt C; Coward RJ
    Nephrol Dial Transplant; 2017 Mar; 32(3):423-433. PubMed ID: 27697843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.
    Zhou L; Liu G; Jia Z; Yang KT; Sun Y; Kakizoe Y; Liu M; Zhou S; Chen R; Yang B; Yang T
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1491-7. PubMed ID: 24005472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms.
    Bełtowski J; Rachańczyk J; Włodarczyk M
    PPAR Res; 2013; 2013():628628. PubMed ID: 23577024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats.
    Wang H; Liu H; Jia Z; Guan G; Yang T
    PPAR Res; 2010; 2010():601562. PubMed ID: 20671947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kidney-specific gene targeting: insight into thiazolidinedione-induced fluid retention.
    Yang T
    Nephrology (Carlton); 2006 Jun; 11(3):201-6. PubMed ID: 16756632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluid retention mediated by renal PPARgamma.
    Staels B
    Cell Metab; 2005 Aug; 2(2):77-8. PubMed ID: 16098822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.
    Guan Y; Hao C; Cha DR; Rao R; Lu W; Kohan DE; Magnuson MA; Redha R; Zhang Y; Breyer MD
    Nat Med; 2005 Aug; 11(8):861-6. PubMed ID: 16007095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears.
    Mao Z; Ong AC
    Nephron Clin Pract; 2009; 112(4):c230-41. PubMed ID: 19546582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.